Sexual behaviour and multiple infections in drug abusers.
We have studied the prevalence and the serological profile of HBV, HCV, HDV and HIV infections in 137 Italian subjects addicted to the intravenous use of heroine and correlated the virological findings with sexual behaviour.
HBV and HCV viremia were also measured in 114 patients.
Anti-HCV was detected in 81% of the addicts, and one or more markers of HBV infection were detected in 62.8% (4.4% were carriers of HBsAg, 58.4% had evidence of past HBV infection and 13.1% of the latter also had HDV markers).
Anti-HIV was positive in 23.4% ; 26% of those positive for anti-HCV and 4.6% of those positive for HBV markers had no other viral marker : none had only anti-HIV.
HBV-DNA was negative in the carriers of HBsAg, and HCV-RNA was not detected in any of the HBsAg carriers who also had circulating anti-HCV.
Overall, 34% of the anti-HCV positive addicts had HCV-RNA in their blood.
The prevalence of the virus infection correlated with the duration of drug addiction but not with sexual behaviour, and sexual behaviour did not influence the acquisition of any virus.
HCV infection was most frequent and probably the first infection to occur, but exposure to HBV was also common despite a low rate of HBsAg carriage.
The prevalence of HDV infection was high (50%) in the HBsAg carriers, while the overall prevalence of HIV was lower (23%) than expected.
Lack of HBV-DNA and HCV-RNA in carriers of HBV with anti-HCV in serum may indicate that HBV and HCV mutually inhibit their own replication.
Mots-clés Pascal : Hépatite virale A, Virose, Infection, Hépatite virale B, Hépatite virale delta, SIDA, Sérologie, Prévalence, Epidémiologie, Comportement sexuel, Toxicomanie, Voie intraveineuse, Homme, Italie, Europe, Association, Appareil digestif pathologie, Foie pathologie, Immunopathologie, Immunodéficit
Mots-clés Pascal anglais : Viral hepatitis A, Viral disease, Infection, Viral hepatitis B, Viral hepatitis delta, AIDS, Serology, Prevalence, Epidemiology, Sexual behavior, Drug addiction, Intravenous administration, Human, Italy, Europe, Association, Digestive diseases, Hepatic disease, Immunopathology, Immune deficiency
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 96-0487376
Code Inist : 002B05C02G. Création : 10/04/1997.